Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro

Experimental Eye Research

Volumn 83, Issue 5, 2006, Pages 1052-1062

  Chen, Jiann Torng ^a   Chen, Po Liang ^a   Chang, Yun Hsiang ^a   Chien, Ming Wei ^a   Chen, Yi Hao ^a   Lu, Da Wen ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

cytokine; glucosamine sulfate; intercellular adhesion molecule 1; leukocyte adhesion; retinal pigment epithelial cell

Indexed keywords

GAMMA INTERFERON; GLUCOSAMINE SULFATE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SUBUNIT; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ADHERENCE INHIBITION; NEUTROPHIL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REPORTER GENE; WESTERN BLOTTING;

CELL ADHESION; CELLS, CULTURED; CYTOKINES; DRUG SYNERGISM; EYE PROTEINS; FLOW CYTOMETRY; GLUCOSAMINE; HUMANS; I-KAPPA B PROTEINS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; LEUKOCYTES; NEUTROPHILS; NF-KAPPA B; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSLOCATION, GENETIC;

EID: 33748882585     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.05.010     Document Type: Article

References (45)

1. Abraham C., Griffith J., and Miller J. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J. Immunol. 162 (1999) 4399-4405
2. Altman R.D., and Lozada C.J. Practice guidelines in the management of osteoarthritis. Osteoarthritis Cartilage 6 Suppl A (1998) 22-24
3. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13-20
4. Baldwin Jr. A. The NF-κB and IκB proteins: new discoveries and insights. Ann. Rev. Immunol. 14 (1996) 649-683
5. Barnes P.J. Nuclear factor-kappa B. Int. J. Biochem. Cell. Biol. 29 (1977) 867-870
6. Becker J.C., Dummer R., Hartmann A.A., Burg G., and Schmidt R.E. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α. Functional consequence on cell-mediated cytotoxicity. J. Immunol. 147 (1991) 4398-4401
7. Bhattacherjee P., Williams R.N., and Eakins K.E. An evaluation of ocular inflammation following the injection of bacterial endotoxin into the rat foot pad. Invest. Ophthalmol. Vis. Sci. 24 (1983) 196-202
8. Bird T.A., Schooley K., Dower S.K., Hagen H., and Virca G.D. Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272 (1997) 32606-32612
9. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., and Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9 (1995) 899-909
10. Epstein F.H. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory disease. N. Engl. J. Med. 336 (1997) 1066-1071
11. Chen J.T., Liang J.B., Chou C.L., Chien M.W., Shyu R.C., Chou P.I., and Lu D.W. Glucosamine sulfate inhibits TNF-α and IFN-γ-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. Invest. Ophthalmol. Vis. Sci. 47 (2006) 664-672
12. Du H.S., McKinnon A., McMenamin P.G., and Forrester J.V. Ultrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental pinealitis. Br. J. Ophthalmol. 75 (1991) 391-397
13. Edwards R.B. Culture of mammalian retinal pigment epithelium and neural retina. Methods Enzymol. 81 (1982) 39-43
14. Elner S.G., Elner V.M., Pavilack M.A., Todd III R.F., Mayo-Bond L., Franklin W.A., Strieter R.M., Kunkel S.L., and Huber A.R. Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest. 66 (1992) 200-211
15. Fenton J.I., Chlebek-Brown K.A., Peters T.L., Caron J.P., and Orth M.W. The effects of glucosamine derivatives on equine articular cartilage. Osteoarthritis Cartilage 8 (2000) 444-451
16. Forrester J.V., Liversidge J., and Dua H.S. Regulation of the local immune response by retinal cells. Curr. Eye Res. 9 suppl. (1990) 183-191
17. Gouze J.N., Bianchi A., Becuwe P., Dauca M., Netter P., Magdalou J., Terlain B., and Bordji K. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett. 510 (2002) 166-170
18. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., and Dustin M.L. The immunological synapse: a molecular machine controlling T cell activation. Science 285 (1999) 221-227
19. Heidenkummer H.P., and Kampik A. Intercellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated antigen-1 (LFA-1) expression in human epiretinal membranes. Graefe's Arch. Clin. Exp. Ophthalmol. 230 (1992) 483-487
20. Homandberg G., Wen C., and Hui F. Agents that block fibronectin fragment-mediated cartilage damage also promote repair. Inflamm. Res. 46 (1997) 467-471
21. Larcher C., Recheis H., Sgoncc R., Gottinger W., Huemer H.P., and Irschick E.U. Influence of viral infection on expression of cell surface antigens in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 235 11 (1997) 709-716
22. Largo R., Alvarez-Soria M.A., and Diez-Ortego I. Glucosamine inhibits IL-1β-induced NF-κ activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11 (2003) 290-298
23. Limb G.A., Little B.C., Meager A., Ogilvie J.A., Wolstencroft R.A., Franks W.A., Chignell A.H., and Dumonde D.C. Cytokines in proliferative vitreoretinopathy. Eye 5 part 6 (1991) 686-693
24. Limb G.A., Early O., Jones S.E., LeRoy F., Chignell A.H., and Dumonde D.C. Expression of mRNA coding for TNF-alpha, IL-1-beta and IL-6 by cells infiltrating retinal membranes. Graefe's Arch. Clin. Exp. Ophthalmol. 232 (1994) 646-651
25. Limb G.A., Alam A., Early O., Green W., Chignell A.H., and Dumonde D.C. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr. Eye Res. 13 (1994) 791-798
26. Ma L., Rudert W.A., Harnaha J., Wright M., Machen J., Lakomy R., Qian S., Lu L., Rubbins P.D., Trucco M., and Giannoukakis N. Immunosuppressive effects of glucosamine. J. Biol. Chem. 277 (2002) 39343-39349
27. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., and Rao A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278 (1997) 860-866
28. Muller-Fassbender H., Bach G.L., Hasse W., Rovati L.C., and Setnikar L. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 2 (1994) 61-69
29. Nagineni C.N., Detick B., and Hooks J.J. Synergistic effects of gamma interferon on inflammatory mediators that induce interleukin-6 gene expression and secretion by human retinal pigment epithelial cells. Clin. Diagn. Lab. Immunol. 1 (1994) 569-577
30. O'Neill H.C., and Parish C.R. Monosaccharide inhibition of cytotoxic T-cell function: demonstration of clone-specific effects. Immunology 64 (1988) 181-184
31. Ossanna P.J., Test S.T., Matheson N.R., Regiani S., and Weiss S.J. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions. J. Clin. Invest. 77 (1986) 1939-1951
32. Pavelka K., Gatterova J., Gollerova V., Urbanova Z., Sedlackova M., and Altman R.D. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure-modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cartilage 8 (2000) 335-342
33. Platts K.E., Benson M.T., Rennie I.G., Sharrard R.M., and Rees R.C. Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 36 (1995) 2262-2269
34. Pober J.S., and Cotran R.S. Cytokines and endothelial cell biology. Physiol. Rev. 70 (1990) 427-451
35. Reginster J.Y., Deroisy R., and Rovati L.C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
36. Rosenbaum J.T., McDevitt H.O., Guss R.B., and Egbert P.R. Endotoxin-induced uveitis in rats as a model for human disease. Nature 286 (1980) 611-613
37. Sandy J., Thompson V., Verscharen C., and Gamett D. Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid. Arch. Biochem. Biophys. 367 (1999) 258-264
38. Shikhman A.R., Kuhn K., Alaaeddine N., and Lotz M. N-acetylglucosamine prevents IL-1β-mediated activation of human chondrocytes. J. Immunol. 166 (2001) 5155-5160
39. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
40. van de Stolpe A., and van der Saag P.T. Intercellular adhesion molecule-1. J. Mol. Med. 74 (1996) 13-33
41. Voraberger G., Schafer R., and Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J. Immunol. 147 (1991) 2777-2786
42. Wakefield D., and Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye diseases. Cytokine 4 (1992) 1-5
43. Wawryk S.O., Cockerill P.N., Wicks I.P., and Boyd A.W. Isolation and characterization of the promoter region of the human intercellular adhesion molecule-1 gene. Int. Immunol. 3 (1991) 83-93
44. Woronicz J.D., Gao X., Gao Z., Rothe M., and Goeddel D.V. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278 (1997) 866-869
45. Yagita M., Nakajima M., and Saksela E. Suppression of human natural killer cell activity by amino sugars. Cell Immunol. 122 (1989) 83-95